Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn E Quelle

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|September 9, 2023
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor TherapyEllen Voigt, Dawn E Quelle
Cancers|December 30, 2014
p53 Acetylation: Regulation and ConsequencesSara M Reed, Dawn E Quelle
Oncotarget|September 30, 2024
Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumorsJoshua J Lingo, Ellen Voigt, Dawn E Quelle
Molecular and Cellular Biology|December 12, 2001
ARF function does not require p53 stabilization or Mdm2 relocalizationChandrashekhar Korgaonkar, Lili Zhao, Modestos Modestou, et al.
Cancers|July 29, 2025
Novel Therapeutics and the Path Toward Effective Immunotherapy in Malignant Peripheral Nerve Sheath TumorsJoshua J Lingo, Elizabeth C Elias, Dawn E Quelle
Cell Cycle (Georgetown, Tex.)|April 24, 2014
ARF sees Pdgfrβ through the miRSara M Reed, Frederick W Quelle, Dawn E Quelle
Cell Cycle (Georgetown, Tex.)|April 4, 2006
Identification of novel ARF binding proteins by two-hybrid screeningVan Tompkins, Jussara Hagen, Valerie P Zediak, et al.
Hybridoma (2005)|June 28, 2008
Generation and characterization of monoclonal antibodies to NIAM: a nuclear interactor of ARF and Mdm2Jussara Hagen, Van Tompkins, Amel Dudakovic, et al.
Molecular Cancer Research : MCR|January 31, 2003
Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathwaysLili Zhao, Tina Samuels, Sarah Winckler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2025
Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from The All of Us Research ProgramTao Xu, Joseph S Dillon, Dawn E Quelle, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|September 9, 2023
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor TherapyEllen Voigt, Dawn E Quelle
Cancers|December 30, 2014
p53 Acetylation: Regulation and ConsequencesSara M Reed, Dawn E Quelle
Oncotarget|September 30, 2024
Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumorsJoshua J Lingo, Ellen Voigt, Dawn E Quelle
Molecular and Cellular Biology|December 12, 2001
ARF function does not require p53 stabilization or Mdm2 relocalizationChandrashekhar Korgaonkar, Lili Zhao, Modestos Modestou, et al.
Cancers|July 29, 2025
Novel Therapeutics and the Path Toward Effective Immunotherapy in Malignant Peripheral Nerve Sheath TumorsJoshua J Lingo, Elizabeth C Elias, Dawn E Quelle
Cell Cycle (Georgetown, Tex.)|April 24, 2014
ARF sees Pdgfrβ through the miRSara M Reed, Frederick W Quelle, Dawn E Quelle
Cell Cycle (Georgetown, Tex.)|April 4, 2006
Identification of novel ARF binding proteins by two-hybrid screeningVan Tompkins, Jussara Hagen, Valerie P Zediak, et al.
Hybridoma (2005)|June 28, 2008
Generation and characterization of monoclonal antibodies to NIAM: a nuclear interactor of ARF and Mdm2Jussara Hagen, Van Tompkins, Amel Dudakovic, et al.
Molecular Cancer Research : MCR|January 31, 2003
Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathwaysLili Zhao, Tina Samuels, Sarah Winckler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2025
Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from The All of Us Research ProgramTao Xu, Joseph S Dillon, Dawn E Quelle, et al.
Pageof 6